Key result
Platelet hyperaggregability is linked to markedly increased platelet malonyldialdehyde formation versus normal controls.
Why the study?
Does platelet malonyldialdehyde formation indicate platelet hyperfunction in patients with enhanced platelet aggregation?
Population
48 subjects: 25 normal controls and 23 patients. Group III had diabetes mellitus, nephrotic syndrome, or…
Comparison
Measurement of platelet malonyldialdehyde… vs Normal controls and patients with normal…
Design
Case-control
Authors
Loading...
MDA formation may mark platelet hyperfunction in observational settings; leaves open its clinical utility pending prospective validation.
Observational (n=48)
Does platelet malonyldialdehyde formation indicate platelet hyperfunction in patients with enhanced platelet aggregation?
p-value: p=<0.0005
Platelet malonyldialdehyde formation is a simple technique that can detect platelet hyperfunction, suggesting intrinsic platelet prostaglandin synthesis involvement.
Marie J. Stuart (1979) conducted an observational in Platelet hyperfunction (n=48). Platelet hyperaggregability vs. Normal controls was evaluated on Platelet malonyldialdehyde formation in the presence of N-ethyl maleimide (NEM) or thrombin (p=<0.0005). Platelet hyperaggregability was associated with markedly increased platelet malonyldialdehyde formation compared to normal controls (p <0.0005).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: